UK Markets open in 4 hrs 47 mins
NIKKEI 225
27,473.09 +87.84 (+0.32%) HANG SENG
19,587.51 -328.17 (-1.65%) CRUDE OIL
69.18 -0.08 (-0.12%) GOLD FUTURES
1,975.90 -7.90 (-0.40%) DOW
32,237.53 +132.33 (+0.41%) BTC-GBP
22,760.68 +189.85 (+0.84%)
Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 169.98 |
| 52-week low 3 | 125.36 |
| 50-day moving average 3 | 147.10 |
| 200-day moving average 3 | 149.02 |
Share statistics
| Avg vol (3-month) 3 | 526.99k |
| Avg vol (10-day) 3 | 506.17k |
| Shares outstanding 5 | 62.97M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 61.22M |
| % held by insiders 1 | 2.51% |
| % held by institutions 1 | 96.00% |
| Shares short (30 Jan 2023) 4 | 2.58M |
| Short ratio (30 Jan 2023) 4 | 5.65 |
| Short % of float (30 Jan 2023) 4 | 4.69% |
| Short % of shares outstanding (30 Jan 2023) 4 | 4.10% |
| Shares short (prior month 29 Dec 2022) 4 | 2.7M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | -0.52% |
| Operating margin (ttm) | 27.02% |
Management effectiveness
| Return on assets (ttm) | 5.30% |
| Return on equity (ttm) | -0.56% |
Income statement
| Revenue (ttm) | 3.58B |
| Revenue per share (ttm) | 57.66 |
| Quarterly revenue growth (yoy) | 12.20% |
| Gross profit (ttm) | 2.88B |
| EBITDA | 1.62B |
| Net income avi to common (ttm) | -18.69M |
| Diluted EPS (ttm) | 4.22 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 899.36M |
| Total cash per share (mrq) | 14.28 |
| Total debt (mrq) | 5.81B |
| Total debt/equity (mrq) | 211.81 |
| Current ratio (mrq) | 3.16 |
| Book value per share (mrq) | 65.15 |
Cash flow statement
| Operating cash flow (ttm) | 1.11B |
| Levered free cash flow (ttm) | 1.54B |
© 2023 Yahoo. All rights reserved.
